Editorial: anemia management with erythropoiesis-stimulating agents: a risk-benefit update
- PMID: 18458117
- DOI: 10.1634/theoncologist.13-S3-1
Editorial: anemia management with erythropoiesis-stimulating agents: a risk-benefit update
Comment on
-
Recombinant human erythropoietins and cancer patients: updated meta-analysis of 57 studies including 9353 patients.J Natl Cancer Inst. 2006 May 17;98(10):708-14. doi: 10.1093/jnci/djj189. J Natl Cancer Inst. 2006. PMID: 16705125
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical